|
Market Closed -
Australian S.E.
13:58:07 21/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.3650 AUD | -2.67% |
|
-2.67% | -43.85% |
| Market Cap | 109M 78.36M 67.1M 62.71M 57.41M 108M 7.5B 742M 289M 3.77B 294M 288M 12.46B | P/E 2026 * |
-5.98x | P/E 2027 * | -4.29x |
|---|---|---|---|---|---|
| Enterprise Value | 115M 82.11M 70.32M 65.72M 60.16M 113M 7.86B 777M 303M 3.95B 308M 302M 13.05B | EV / Sales 2026 * |
14.7x | EV / Sales 2027 * | 10.7x |
| Free-Float |
62.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.67% | ||
| 1 week | -2.67% | ||
| Current month | -1.35% | ||
| 1 month | +1.39% | ||
| 3 months | -25.51% | ||
| 6 months | -36.52% | ||
| Current year | -43.85% |
| 1 week | 0.36 |  | 0.38 |
| 1 month | 0.35 | | 0.38 |
| Current year | 0.35 | | 0.73 |
| 1 year | 0.35 | | 0.73 |
| 3 years | 0.28 | | 0.73 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 28/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 01/10/2012 |
James Graham
BRD | Director/Board Member | - | 01/05/2012 |
| Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 31/7/26 | Buy | Chief Executive Officer | 25,000 | 0.0083% | ||
| 31/7/26 | Buy | Director | 75,000 | 0.0250% | ||
| 31/7/26 | Buy | Director | 37,500 | 0.0125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.67% | -2.67% | -9.88% | -49.31% | 79.96M | |
| +0.88% | +3.84% | +77.96% | +129.75% | 1,109B | |
| +1.07% | +3.11% | +51.11% | +56.67% | 644B | |
| +1.20% | +5.64% | +26.68% | +76.48% | 463B | |
| +1.02% | +3.67% | +43.14% | +47.27% | 371B | |
| +0.85% | +2.97% | +24.48% | +42.54% | 301B | |
| +1.26% | +4.54% | +2.20% | +14.84% | 256B | |
| +1.88% | +5.14% | +48.20% | +67.80% | 234B | |
| +1.59% | +0.87% | -12.95% | -51.91% | 205B | |
| +1.87% | +5.78% | +23.07% | +92.57% | 178B | |
| Average | +0.72% | +2.70% | +27.40% | +42.67% | 376.11B | |
| Weighted average by Cap. | +0.73% | +3.26% | +44.79% | +72.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.78M 5.58M 4.78M 4.46M 4.09M 7.67M 534M 52.78M 20.59M 268M 20.94M 20.48M 887M | 12.5M 8.96M 7.67M 7.17M 6.56M 12.32M 857M 84.78M 33.07M 431M 33.63M 32.9M 1.42B |
| Net income | -18.29M -13.11M -11.23M -10.5M -9.61M -18.04M -1.25B -124M -48.41M -630M -49.24M -48.16M -2.08B | -25.1M -17.99M -15.41M -14.4M -13.18M -24.75M -1.72B -170M -66.43M -865M -67.56M -66.08M -2.86B |
| Net Debt | 5.24M 3.75M 3.21M 3M 2.75M 5.16M 359M 35.52M 13.86M 180M 14.09M 13.78M 597M | 24.96M 17.9M 15.33M 14.32M 13.11M 24.62M 1.71B 169M 66.07M 860M 67.19M 65.72M 2.84B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | A$0.3650 | -2.67% | 230,817 |
| 20/08/26 | A$0.3750 | -2.60% | 34,406 |
| 19/08/26 | A$0.3850 | +1.32% | 23,226 |
| 18/08/26 | A$0.3800 | -1.30% | 13,762 |
| 17/08/26 | A$0.3850 | +4.05% | 31,851 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
